Judge Gives Par Pharma Shareholders 2nd Chance
Shareholders have 30 days to amend securities fraud claims against Par Pharmaceutical Co. Inc. and its top executives after a judge threw out their consolidated class action complaint on Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article